Guardant Health (GH) Is Up 25.3% After FDA Clears First Genomic‑Epigenomic Liquid Biopsy Panel – Has The Bull Case Changed?
On May 20, 2026, Guardant Health received FDA approval for Guardant360 Liquid CDx, the largest FDA-approved liquid biopsy…
